On Monday, Clover Health Investments Corp (NASDAQ: CLOV) was 1.21% up from the session before settling in for the closing price of $2.88. A 52-week range for CLOV has been $1.01 – $4.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 36.85%. With a float of $382.10 million, this company’s outstanding shares have now reached $388.51 million.
Let’s look at the performance matrix of the company that is accounted for 570 employees. In terms of profitability, gross margin is 26.37%, operating margin of -1.64%, and the pretax margin is -1.64%.
Clover Health Investments Corp (CLOV) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Clover Health Investments Corp stocks. The insider ownership of Clover Health Investments Corp is 24.92%, while institutional ownership is 20.90%. The most recent insider transaction that took place on Mar 07 ’25, was worth 722,000. In this transaction Director of this company sold 200,000 shares at a rate of $3.61, taking the stock ownership to the 273,227 shares. Before that another transaction happened on Mar 06 ’25, when Company’s CEO of Home Care sold 75,000 for $3.68, making the entire transaction worth $276,000. This insider now owns 2,418,151 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 36.85% per share during the next fiscal year.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
You can see what Clover Health Investments Corp (CLOV) is doing with its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Clover Health Investments Corp (NASDAQ: CLOV) saw its 5-day average volume 5.45 million, a negative change from its year-to-date volume of 6.02 million. As of the previous 9 days, the stock’s Stochastic %D was 16.69%. Additionally, its Average True Range was 0.13.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 5.80%, which indicates a significant decrease from 17.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 20.34% in the past 14 days, which was lower than the 53.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.35, while its 200-day Moving Average is $3.56. Nevertheless, the first resistance level for the watch stands at $2.99 in the near term. At $3.07, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.12. If the price goes on to break the first support level at $2.86, it is likely to go to the next support level at $2.81. Assuming the price breaks the second support level, the third support level stands at $2.73.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
There are 508,917K outstanding shares of the company, which has a market capitalization of 1.49 billion. As of now, sales total 1,371 M while income totals -43,010 K. Its latest quarter income was 462,330 K while its last quarter net income were -1,270 K.
